ATE284706T1 - Neue verbesserte formulierung zur behandlung von thromboembolismus - Google Patents

Neue verbesserte formulierung zur behandlung von thromboembolismus

Info

Publication number
ATE284706T1
ATE284706T1 AT97926326T AT97926326T ATE284706T1 AT E284706 T1 ATE284706 T1 AT E284706T1 AT 97926326 T AT97926326 T AT 97926326T AT 97926326 T AT97926326 T AT 97926326T AT E284706 T1 ATE284706 T1 AT E284706T1
Authority
AT
Austria
Prior art keywords
thromboembolism
treatment
new improved
improved formulation
formulation
Prior art date
Application number
AT97926326T
Other languages
English (en)
Inventor
Jan-Erik Loefroth
Lennart Lindfors
Anna-Lena Ungell
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE284706T1 publication Critical patent/ATE284706T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
AT97926326T 1996-05-31 1997-05-28 Neue verbesserte formulierung zur behandlung von thromboembolismus ATE284706T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602145A SE9602145D0 (sv) 1996-05-31 1996-05-31 New improved formulation for treatment of thromboembolism
PCT/SE1997/000914 WO1997045138A1 (en) 1996-05-31 1997-05-28 New improved formulation for treatment of thromboembolism

Publications (1)

Publication Number Publication Date
ATE284706T1 true ATE284706T1 (de) 2005-01-15

Family

ID=20402816

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97926326T ATE284706T1 (de) 1996-05-31 1997-05-28 Neue verbesserte formulierung zur behandlung von thromboembolismus

Country Status (14)

Country Link
US (1) US6673365B1 (de)
EP (1) EP1015022B1 (de)
JP (1) JP2000511526A (de)
AR (1) AR013569A1 (de)
AT (1) ATE284706T1 (de)
AU (1) AU722450B2 (de)
CA (1) CA2253410A1 (de)
DE (1) DE69731981T2 (de)
ID (1) ID19472A (de)
NO (1) NO985558L (de)
NZ (1) NZ332788A (de)
SE (1) SE9602145D0 (de)
WO (1) WO1997045138A1 (de)
ZA (1) ZA974386B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464175A (en) * 1982-08-25 1984-08-07 Altman Alan R Multipurpose tamponade and thrombosclerotherapy tube
US4568545A (en) * 1982-10-02 1986-02-04 Amano Seiyaku Kabushiki Kaisha Thrombolytic agent
EP0662826A1 (de) 1992-10-02 1995-07-19 Pfizer Inc. Pharmazeutische zusammensetzungen enthaltend nichtionische tenside
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9302135D0 (sv) * 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation

Also Published As

Publication number Publication date
DE69731981D1 (de) 2005-01-20
ID19472A (id) 1998-07-16
NO985558D0 (no) 1998-11-27
SE9602145D0 (sv) 1996-05-31
AU3111597A (en) 1998-01-05
ZA974386B (en) 1997-12-01
AR013569A1 (es) 2001-01-10
CA2253410A1 (en) 1997-12-04
NZ332788A (en) 2000-05-26
AU722450B2 (en) 2000-08-03
EP1015022A1 (de) 2000-07-05
DE69731981T2 (de) 2005-12-22
US6673365B1 (en) 2004-01-06
EP1015022B1 (de) 2004-12-15
JP2000511526A (ja) 2000-09-05
WO1997045138A1 (en) 1997-12-04
NO985558L (no) 1998-11-27

Similar Documents

Publication Publication Date Title
DE69732152D1 (de) Vorrichtung zur Behandlung von Kopfschmerzen
ATE240107T1 (de) Neue verbesserte formulierung zur behandlung der osteoporose
ATE259812T1 (de) Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen
DE69739303D1 (de) Vorrichtung zur thermischen behandlung von gewebe
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69509544D1 (de) Zusammensetzung zur behandlung ovarieller östrogenabhängiger krankheiten
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATA46794A (de) Einrichtung zur behandlung von hautzonen
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE69603089T2 (de) Zusammensetzung zur behandlung von mauerwerk
DE69711311T2 (de) Vorrichtung zur thermischen Behandlung von Gewebe
DE69729817D1 (de) Behandlung von Aldehyd-fixierten Geweben
DE69519577D1 (de) Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69727240D1 (de) Kombinationen enthaltend vx478, zidovudin und 3tc zur behandlung von hiv
DE69737067D1 (de) Vakzine zur behandlung von mycosen
DE69807466D1 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
DE69735417D1 (de) 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69412178T2 (de) Apparat zur Behandlung von Lagen
DE69731981D1 (de) Neue verbesserte formulierung zur behandlung von thromboembolismus
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties